Pfizer Ltd. — Regulatory Filings 2021

Jul 16, 2021

Pfizer Limited

==> picture [100 x 41] intentionally omitted <==

The Capital, 1802/1901, Plot No. C - 70, G Block, Bandra Kurla Complex, Bandra (East), Mumbai 400 051. Tel : +91 22 6693 2000 Fax : +91 22 2654 0274

July 16, 2021

The Corporate Relationship Dept. BSE Limited[st] Floor, P.J.Towers Dalal Street, Fort Mumbai - 400 001 Scrip Code: 500680

The Manager, Listing Dept. The National Stock Exchange of India Ltd. Exchange Plaza, 5[th] Floor, Plot No. C/1, G Block Bandra-Kurla Complex, Bandra (E) Mumbai - 400 051 Scrip Symbol: PFIZER

Dear Sirs,

Sub: Board Meeting for the Unaudited Financial Results for the quarter ended

June 30, 2021.

Ref: Regulation 29 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

This is to inform you that a meeting of the Board of Directors of the Company is scheduled to be held on Wednesday, July 28, 2021, inter alia, to consider and take on record the Unaudited Financial Results of the Company for the quarter ended June 30, 2021.

Pursuant to the “Pfizer Limited – Code of Internal Procedures and Conduct to Regulate, Monitor and Report Trading by Insiders”, the Trading Window of the Company was closed from Wednesday, June 30, 2021 (close of business) till 48 hours after the results are made public on July 28, 2021.

We request you to kindly take the same on record.

Thanking you,

Yours truly,

For Pfizer Limited

==> picture [111 x 55] intentionally omitted <==

Prajeet Nair Company Secretary

Cc: National Securities Depository Limited (NSDL) Central Depository Services (India) Limited (CDSL)

KFin Technologies Private Limited

CIN: L24231MH1950PLC008311 Email ID: contactus.india@pfizer.com Website: www.pfizerindia.com